|
Toms Skoわたなべ2015年7月2日 "No question, we are coming down on the side of safety," Smith said. "The company takes the position that we don't want to endanger anybody. At the time that the experimental treatment was being considered for Dr. Sheik Humarr Khan, his immune system was already starting to produce antibodies suggesting he might recover, Doctors Without Borders said in the statement. [参考] |
コメントはありません |